A Wheaton, Ill., startup founded by an ophthalmologist is working on an artificial silicon retina that could restore sight to those suffering from macular degeneration-the leading cause of blindness in people older than 65. The device is a silicon wafer 3 millimeters across covered with photodiodes. With the wafer implanted in the retina, the photodiodes convert light into electrical impulses that travel through the optic nerve to the brain. The photodiodes will be packed so densely that the “resolution will theoretically be as good as normal vision,” says Optobionics founder Alan Chow; Stanford University’s Nanofabrication Center is collaborating on the miniaturization.
The implant has induced retinal activity in animals, but studies with human volunteers are more than a year away. Because the photodiodes are sensitive to infrared as well as visible light, Chow says these first subjects may report some odd sightings, such as beams shooting from a TV remote control.
Embracing CX in the metaverse
More than just meeting customers where they are, the metaverse offers opportunities to transform customer experience.
Identity protection is key to metaverse innovation
As immersive experiences in the metaverse become more sophisticated, so does the threat landscape.
The modern enterprise imaging and data value chain
For both patients and providers, intelligent, interoperable, and open workflow solutions will make all the difference.
Scientists have created synthetic mouse embryos with developed brains
The stem-cell-derived embryos could shed new light on the earliest stages of human pregnancy.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.